IntenOxy 5™ Stationary Oxygen Concentrator Valuable Addition to Respiratory Patient Care
Ball Ground, GA (January 31, 2025)—Durable and home medical equipment providers in the United States will now have another solution to meet their respiratory patients’ at-home oxygen therapy needs. Today, CAIRE announced the addition of the new IntenOxy 5™ stationary oxygen concentrator to its portfolio at its global manufacturing headquarters north of Atlanta.
According to an article published in the National Library of Medicine database, the Centers for Medicare & Medicaid Services estimate that more than 1 million Medicare recipients receive long-term oxygen therapy (LTOT) at home.*
The IntenOxy 5 offers effective oxygen delivery with up to 95.5 percent concentration and flow settings from 0.5 to 5 liters per minute (LPM), meeting a broad range of prescription needs.
Patients will appreciate its simple user interface with easy-to-understand alerts. Weighing only 34.2 lbs., this concentrator is sleek and compact, blending into the surroundings and boasting a low power consumption of <350W at the 5 LPM setting.
When combined with CAIRE’s award-winning FreeStyle Comfort portable oxygen concentrator, the IntenOxy 5 provides yet another solution to help DME and HME customers stock their fleets with what the industry calls non-delivery solutions—equipment that requires minimal maintenance and reduces overall operating expenses.
“The IntenOxy 5 Stationary Oxygen Concentrator has been an excellent addition to our oxygen therapy portfolio. The unit is a key component to how our DME and HME customers serve their respiratory patients, providing them with an at-home device that delivers the oxygen they need as they navigate activities of daily living,” said Ken Hosako, CAIRE President and Chief Executive Officer.
The unit has a three-year warranty and will soon be available in Canada. For more information, visit https://www.caireinc.com/product/intenoxy-5-provider/ or email customerservice.usa@caireinc.com.
Ref: MR-CORP0032 A
*More information can be found online at the National Library of Medicine: https://pmc.ncbi.nlm.nih.gov/articles/PMC2897694/. Stoller, J. K., Panos, R. J., Krachman, S., Doherty, D. E., Make, B., and the Long-term Oxygen Treatment Trial Group. Oxygen Therapy for Patients with COPD: Current Evidence and the Long-Term Oxygen Treatment Trial. Chest, 2010 Jul;138(1):179–187. doi: 10.1378/chest.09-2555